CA Patent

CA3237768A1 — Combination of turso and sodium phenyl butyrate for the treatment of neurodegenerative diseases

Assigned to Amylyx Pharmaceuticals Inc · Expires 2023-05-11 · 3y expired

What this patent protects

Provided herein are methods and compositions for treating a neurodegenerative disease (e.g., AD or PSP). The methods can include administering to the subject a bile acid or a pharmaceutically acceptable salt thereof and a phenylbutyrate compound.

USPTO Abstract

Provided herein are methods and compositions for treating a neurodegenerative disease (e.g., AD or PSP). The methods can include administering to the subject a bile acid or a pharmaceutically acceptable salt thereof and a phenylbutyrate compound.

Drugs covered by this patent

Patent Metadata

Patent number
CA3237768A1
Jurisdiction
CA
Classification
Expires
2023-05-11
Drug substance claim
No
Drug product claim
No
Assignee
Amylyx Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.